Editor’s Note:The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians, but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using the following patient scenario and corresponding questions. If you have a case that you would like to suggest for a future Case Challenge, … Read more
Archyde > Long-Term Efficacy and Safety of Ritlecitinib in Alopecia Areata Table of Contents 1. Long-Term Efficacy and Safety of Ritlecitinib in Alopecia Areata 2. Promising Results: Hair Regrowth Sustains Over Time 3. Safety Profile: Favorable Despite Side Effects 4. What Are the Key Differences Between the ALLEGRO-LT Study and Previous Ritlecitinib Trials for AA? … Read more
TOPLINE: Ritlecitinib demonstrates long-term improvements in regrowth of scalp hair, eyebrows, and eyelashes at 24 months in adults and adolescents with alopecia areata (AA) and ≥ 25% scalp hair loss. METHODOLOGY: Researchers evaluated outcomes in 449 de novo adult and adolescent patients (mean age, 32.9 years) with AA and ≥ 25% scalp hair loss, enrolled … Read more